Platinum nanoparticles for selective treatment of liver cancer cells
Researchers at ETH Zurich recently demonstrated that platinum nanoparticles can be used to kill liver cancer cells with greater selectivity than existing cancer drugs.
Researchers at ETH Zurich recently demonstrated that platinum nanoparticles can be used to kill liver cancer cells with greater selectivity than existing cancer drugs.
Bio & Medicine
Feb 14, 2019
0
56
Measuring the toxic effects of chemical compounds on different types of cells is critical for developing cancer drugs, which must be able to kill their target cells. Analyzing cell survival is also an important task in fields ...
Cell & Microbiology
Feb 5, 2019
0
54
Research at the University of Arkansas on membrane proteins could lead to better development and testing of drugs. Chemistry researchers studied a type of membrane protein that expels drugs from a cell, contributing to drug ...
Biochemistry
Jan 22, 2019
0
25
Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects—especially when treating tumors. In the journal Angewandte Chemie, scientists ...
Biochemistry
Oct 30, 2018
0
7
Nanosystems that deliver anticancer drugs or imaging materials to tumours are showing significant progress, particularly those that respond to tumour-related stimuli, according to a review published in the journal Science ...
Bio & Medicine
Oct 30, 2018
0
26
Designing synthetic proteins that can act as drugs for cancer or other diseases can be a tedious process: It generally involves creating a library of millions of proteins, then screening the library to find proteins that ...
Biochemistry
Oct 16, 2018
0
81
Scientists have found a new method for analysing how active agents affect a specific protein essential for cell survival. Their research could help to quickly develop drugs with fewer side effects.
Biochemistry
Aug 28, 2018
0
5
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function ...
Bio & Medicine
Aug 23, 2018
0
24
HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover page of July 2018 issue of the Journal of Chemical Theory and Computation, software ...
Biochemistry
Jul 12, 2018
0
10
A new method has been developed to make drugs 'smarter' using nanotechnology so they will be more effective at reaching their target.
Bio & Medicine
Apr 23, 2018
0
448